References
- Galvin J. E., Lee V. M., Trojanowski J. Q. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001; 58: 186–90
- Dickson D. W. Alpha‐synuclein and the Lewy body disorders. Curr Opin Neurol 2001; 14: 423–32
- Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., et al. Alpha‐Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841
- Farrer M., Kachergus J., Forno L., Lincoln S., Wang D. S., Hulihan M., et al. Comparison of kindreds with Parkinsonism and alpha‐synuclein genomic multiplications. Ann Neurol 2004; 55: 174–9
- Miller D. W., Hague S. M., Clarimon J., Baptista M., Gwinn‐Hardy K., Cookson M. R., et al. Alpha‐synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 2004; 62: 1835–8
- Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., et al. alpha‐Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004; 56: 591–5
- Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G., Goedert M. Binding of alpha‐synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998; 273: 26292–4
- Jensen P. H., Li J. Y., Dahlstrom A., Dotti C. G. Axonal transport of synucleins is mediated by all rate components. Eur J Neurosci 1999; 11: 3369–76
- Li J. Y., Jensen P. H., Dahlstrom A. Differential localization of alpha‐, beta‐ and gamma‐synucleins in the rat CNS. Neuroscience 2002; 113: 463–78
- Lindersson E., Lundvig D., Petersen C., Madsen P., Nyengaard J. R., Hojrup P., et al. p25alpha stimulates alpha‐synuclein aggregation and is co‐localized with aggregated alpha‐synuclein in alpha‐synucleinopathies. J Biol Chem 2005; 280: 5703–15
- Li W., Lesuisse C., Xu Y., Troncoso J. C., Price D. L., Lee M. K. Stabilization of alpha‐synuclein protein with aging and familial Parkinson's disease‐linked A53T mutation. J Neurosci 2004; 24: 7400–9
- Bönsch D., Greifenberg V., Bayerlein K., Biermann T., Reulbach U., Hillemacher T., et al. Alpha‐synucleinprotein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res 2005; 29: 763–5
- Lee P. H., Lee G., Park H. J., Bang Oy., Joo I. S., Huh K. The plasma alpha‐synuclein levels in patients with Parkinson's disease and multiple system atrophy. J Neural Transm 2006; 10: 1435–9
- Miller D. W., Hague S. M., Clarimon J., Baptista M., Gwinn‐Hardy K., Cookson M. R., et al. Alpha‐synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 2004; 25: 1835–8
- Li Q. X., Campbell B. C., McLean C. A., Thyagarajan D., Gai W. P., Kapsa R. M., et al. Platelet alpha and gamma‐synucleins in Parkinson's disease and normal control subjects. J Alzheimers Dis 2002; 4: 309–15
- Kim S., Jeon B. S., Heo C., Im P. S., Ahn T. B., Seo J. H., et al. Alpha‐synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's diseases. FASEB J 2004; 18: 1615–17